EDGC Obtains Patent for Chromosomal Abnormality Detection Method

[Asia Economy Reporter Oh Ju-yeon] EDGC announced on the 22nd that it has obtained a patent in Singapore related to a method for determining chromosomal abnormalities. The company stated, "Sequencing can be performed regardless of the next-generation sequencing platform, enabling the determination of abnormalities in both autosomes and sex chromosomes," and explained, "Unique reads are extracted from the sequenced sequence data to determine the fetal gender."

This content was produced with the assistance of AI translation services.